Activation of KLF10 gene can promote growth inhibition and apoptosis of TGF-β-susceptible human HCC cells, as well as to inhibit stathmin promoter activity, suggesting stathmin is a direct target of KLF10 [79]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.